Back to Search Start Over

Excessive left anterior hippocampal and caudate activation in schizophrenia underlie cognitive underperformance in a virtual navigation task.

Authors :
Zawadzki JA
Girard TA
Samsom J
Foussias G
Siddiqui I
Lerch JP
Grady C
Wong AHC
Source :
Psychiatry research. Neuroimaging [Psychiatry Res Neuroimaging] 2024 Jul; Vol. 341, pp. 111826. Date of Electronic Publication: 2024 May 06.
Publication Year :
2024

Abstract

We used a virtual navigation paradigm in a city environment to assess neuroanatomical correlates of cognitive deficits in schizophrenia spectrum disorders (SSD). We studied a total of N = 36 subjects: 18 with SSD and 18 matched unaffected controls. Participants completed 10 rapid, single-trial navigation tasks within the virtual city while undergoing functional magnetic resonance imaging (fMRI). All trials tested ability to find different targets seen earlier, during the passive viewing of a path around different city blocks. SSD patients had difficulty finding previously-encountered targets, were less likely to find novel shortcuts to targets, and more likely to attempt retracing of the path observed during passive viewing. Based on a priori region-of-interest analyses, SSD participants had hyperactivation of the left hippocampus when passively viewing turns, hyperactivation of the left caudate when finding targets, and hypoactivation of a focal area of the dorsolateral prefrontal cortex when targets were initially shown during passive viewing. We propose that these brain-behaviour relations may bias or reinforce stimulus-response navigation approaches in SSD and underlie impaired performance when allocentric spatial memory is required, such as when forming efficient shortcuts. This pattern may extend to more general cognitive impairments in SSD that could be used to design remediation strategies.<br />Competing Interests: Declaration of competing interest Dr. Foussias has been involved in research sponsored by Medicure Inc., and Neurocrine Bioscience, has received consultant fees from Roche, and has received speaker fees from Roche, Lundbeck, and Novartis. Dr. Wong is a scientific consultant to Lucid psycheceuticals, a subsidiary of FSD Pharma Inc. The other authors declare no competing financial interest.<br /> (Copyright © 2024 Elsevier B.V. All rights reserved.)

Details

Language :
English
ISSN :
1872-7506
Volume :
341
Database :
MEDLINE
Journal :
Psychiatry research. Neuroimaging
Publication Type :
Academic Journal
Accession number :
38735228
Full Text :
https://doi.org/10.1016/j.pscychresns.2024.111826